Plasma biomarkers for mild cognitive impairment and Alzheimer's disease
Open Access
- 1 October 2009
- journal article
- review article
- Published by Elsevier in Brain Research Reviews
- Vol. 61 (2) , 69-80
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Plasma Amyloid β-Protein and C-reactive Protein in Relation to the Rate of Progression of Alzheimer DiseaseArchives of Neurology, 2008
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health StudyNeurology, 2008
- APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central NorwayBMC Neurology, 2008
- Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer diseaseCanadian Medical Association Journal, 2008
- Plasma Lipid Levels in the Elderly Are Not Associated with the Risk of Mild Cognitive ImpairmentDementia and Geriatric Cognitive Disorders, 2008
- Health‐Protective and Adverse Effects of the Apolipoprotein E ɛ2 Allele in Older MenJournal of the American Geriatrics Society, 2008
- Alzheimer's Disease and Mild Cognitive ImpairmentNeurologic Clinics, 2007
- Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodiumNeurobiology of Aging, 2007
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging studyAnnals of Neurology, 2002